You have 9 free searches left this month | for more free features.

tiragolumab

Showing 1 - 25 of 39

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • NSCLC
  • (no location specified)
Apr 5, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 14, 2023

Urothelial Cancer Trial in Beijing (Atezolizumab, RO7247669, Tiragolumab)

Recruiting
  • Urothelial Cancer
  • Beijing, China
    Beijing Cancer Hospital
Jan 18, 2023

Advanced Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial (biological, procedure, drug)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Refractory Malignant Solid Neoplasm
  • Atezolizumab
  • +5 more
  • (no location specified)
Feb 4, 2023

NSCLC Trial (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • (no location specified)
Apr 11, 2023

Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma Trial in Houston (drug, behavioral, radiation)

Not yet recruiting
  • Squamous Cell Carcinoma
  • Oral Cavity Squamous Cell Carcinoma
  • Tiragolumab
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

Locally Advanced Esophageal Squamous Cell Carcinoma Trial (Tiragolumab)

Not yet recruiting
  • Locally Advanced Esophageal Squamous Cell Carcinoma
  • Tiragolumab
  • (no location specified)
Feb 23, 2023

Stage II Melanoma Trial in United States (Atezolizumab, Tiragolumab, Signatera Assay)

Recruiting
  • Stage II Melanoma
  • Duarte, California
  • +5 more
Nov 10, 2022

NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Tiragolumab
  • +3 more
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Feb 16, 2023

Stomach Tumors, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in China (Atezolizumab, Tiragolumab, Oxaliplatin)

Active, not recruiting
  • Stomach Neoplasms
  • +2 more
  • Beijing, China
  • +10 more
Dec 21, 2022

Small Cell Lung Carcinoma Trial in China (Tiragolumab, Atezolizumab, Carboplatin)

Active, not recruiting
  • Small Cell Lung Carcinoma
  • Tiragolumab
  • +4 more
  • Beijing, China
  • +15 more
Aug 15, 2022

Cohort 1 : Metastatic Non Small Cell Lung Cancer, Cohort 2 : Metastatic Bladder Cancer, Cohort 3 : Metastatic Renal Cell

Not yet recruiting
  • Cohort 1 : Metastatic Non Small Cell Lung Cancer
  • +3 more
  • Atezolizumab 60 MG/1 ML Intravenous Solution [TECENTRIQ]
  • +2 more
  • Dijon, Bourgogne, France
    Centre Georges François Leclerc (CGFL)
Feb 18, 2022

Metastatic Malignancy Trial in Houston (Atezolizumab, Tiragolumab)

Not yet recruiting
  • Metastatic Malignancy
  • Houston, Texas
    M D Anderson Cancer Center
Dec 19, 2022

Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma Trial in Korea, Republic of, United States (Tiragolumab,

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Tiragolumab
  • +3 more
  • Denver, Colorado
  • +12 more
Jan 19, 2023

Carcinoma, Small Cell Lung Trial in China (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
  • Carcinoma, Small Cell Lung
  • Beijing City, China
  • +20 more
Dec 15, 2022

NSCLC, Solid Tumor Trial in United States (Atezolizumab, Chemotherapy (Arm A Only), Tiragolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • Solid Tumor
  • Fort Myers, Florida
  • +6 more
Feb 16, 2022

Triple-Negative Breast Cancer Trial in Worldwide (Tiragolumab, Atezolizumab, Nab-paclitaxel)

Active, not recruiting
  • Triple-Negative Breast Cancer
  • Tiragolumab
  • +7 more
  • Birmingham, Alabama
  • +23 more
Jan 19, 2023

Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Worldwide (Mosunetuzumab SC, Tiragolumab, Atezolizumab)

Recruiting
  • Non-Hodgkin Lymphoma, Follicular Lymphoma
  • Mosunetuzumab SC
  • +3 more
  • Ann Arbor, Michigan
  • +14 more
Aug 12, 2022

Renal Cell Carcinoma Trial in Beijing, Seoul (RO7247669, Tiragolumab, Pembrolizumab)

Recruiting
  • Renal Cell Carcinoma
  • Beijing, China
  • +1 more
Mar 28, 2023

Carcinoma, Hepatocellular Trial (Atezolizumab, Bevacizumab, Tiragolumab)

Not yet recruiting
  • Carcinoma, Hepatocellular
  • (no location specified)
Jun 15, 2023

NSCLC (NSCLC) Trial in Worldwide (Atezolizumab, Tiragolumab, Carboplatin)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Duarte, California
  • +23 more
Aug 8, 2022

Advanced/Metastatic Tumors Trial in Worldwide (Atezolizumab, Tiragolumab, Carboplatin)

Active, not recruiting
  • Advanced/Metastatic Tumors
  • Scottsdale, Arizona
  • +27 more
Jan 5, 2023

Esophageal Cancer Trial in Worldwide (Atezolizumab, Tiragolumab, Paclitaxel)

Active, not recruiting
  • Esophageal Cancer
  • Anyang City, China
  • +68 more
Jan 20, 2023

NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Tempe, Arizona
  • +40 more
Nov 11, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +5 more
  • Jacksonville, Florida
  • +2 more
Oct 21, 2022